Unlock stock picks and a broker-level newsfeed that powers Wall Street.
FDA panel recommends approving Collegium's painkiller
Sept 11 (Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration voted in favor of approving Collegium Pharmaceutical Inc's experimental opioid painkiller.
The panel voted 23 to 0 for the approval of the drug, to be called Xtampza.
The FDA's staff had on Wednesday expressed concerns over likely errors in administering Xtampza.
(Reporting by Vidya L Nathan in Bengaluru; Editing by Savio D'Souza)
Terms and Privacy Policy